期刊文献+

急性冠脉综合征患者血清高密度脂蛋白胆固醇、超氧化物歧化酶、游离脂肪酸水平分析 被引量:2

Analysis of Serum High Density Lipoprotein Cholesterol,Super Oxide Dismutase,Non-esterified Fatty Acid Levels in Patients with Acute Coronary Syndrome
下载PDF
导出
摘要 目的:探讨高密度脂蛋白胆固醇(HDL-C)、超氧化物歧化酶(SOD)、游离脂肪酸(NEFA)水平与急性冠脉综合征(ACS)的相关性。方法:选择384例ACS患者为研究组,并选择同期住院的冠状动脉造影示无冠状动脉狭窄的285例非冠心病患者作为对照组,比较两组患者的HDL-C、SOD、NEFA。结果:与对照组比较,研究组HDL-C和SOD水平显著降低(P<0.001),NEFA水平显著升高(JP<0.001);研究组中HDL-C、SOD、NEFA水平均与冠状动脉病变严重程度相关。结论:ACS患者的冠脉病变严重程度和心肌坏死的进展与HDL-C、SOD、NEFA水平密切相关;HDL-C、SOD、NEFA水平的高低可作为预测心肌进一步损伤的重要指标,对冠心病的防治提供重要的临床依据。 Objective:To investigate the levels of high density lipoprotein cholesterol (HDL-C),super oxide dismutase(SOD) and non-esterified fatty acid(NEFA) in patients with acute coronary syndrome(ACS). Methods: A total of 384 patients with ACS diagnosed by coronary angiography were selected as research group , and 285 cases admitted to the hospital in the same period with normal coronary angiogram were selected as control group. The HDL-C,SOD and NEFA were compared between the two groups. Results: The levels of HDL-C and SOD in research group were significantly lower than those in control group(P &lt; 0.001).The level of NEFA in research group was significantly higher than that in control group(P &lt; 0.001). In research group, the levels of HDL-C ,SOD and NEFA were related to the severity of the coronary artery stenosis. Conclusion: There is a compact correlation between the severity of coronary artery disease and the progress of myocardial necrosis with the levels of HDL-C、SOD and NEFA in patients with ACS. The levels of HDL-C、SOD and NEFA can be the important indicators to predict the further damage of myocardial, they are provided important clinical evidence for prevention of coronary heart disease.
出处 《岭南急诊医学杂志》 2014年第2期81-82,85,共3页 Lingnan Journal of Emergency Medicine
基金 国家自然科学基金(81070182) 广东省自然科学基金(10151008901000224)
关键词 高密度脂蛋白胆固醇 超氧化物歧化酶 游离脂肪酸 急性冠脉综合征 high density lipoprotein cholesterol super oxide dismutase non-esterified fatty acid acute coronary syndrome
  • 相关文献

参考文献6

  • 1Shil AB. Termination of Atherothrombosis Intervention in Metabolic Syndrome with Low High -Density Lipoprotein Cholesterol and High Triglycerides: Impact on Global Health Study and decision to use extended- release niacin in elderly [J].J Am Geriatr Soc,2011, 59(12) :2397.
  • 2Khalil A, Berrougui H, Pawelec G,et al. Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti -inflammatory activity in Alzheimer's disease [J]. Mech Ageing Dev,2012,133 (1):20.
  • 3Shao B. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA 1, a key cardioprotective function of HDL [J]. Biochim Biophys Acta, 2012,1821(3) :490.
  • 4Peters S A, Lind L, Palmer M K, et al. Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: the METEOR study [J]. J Intern Med,2012,272(3):257.
  • 5Posadas-Sanchez R, Posadas-Romero C, Mendoza- Perez E, et al. Cholesterol efflux and metabolic abnormalities associated with low high density lipoprotein cholesterol and high triglycerides in statin- treated coronary men with low density lipoprotein cholesterol <70 mg/dl [J]. Am J Cardiol,2012,109 (5):636.
  • 6Zhou Z, Liu Y, Miao AD, et al. Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells [J]. Eur J Pharmacol,2005,513(1-2) : 1.

同被引文献29

  • 1Naghavi M, Libby P, Falk E,et al. From vulnerable plaque tovulnerable patient : a call for new definitions and risk assessmentstrategies ; Part I[ J] . Circulation , 2003 ,108( 14) : 1664-1672.
  • 2Ma R, Zhang W, Wang T, et al. Pentraxin 3, long expression inmononuclear cells of patients with acute coronary syndrome : Correla-tion with C-reactive protein and matrix metalloproteinase-9 levels[ J].J Int Med Res, 2014,42(3) :677-683.
  • 3Chandrasekar B, Mummidi S, Mahimainathan L, et al. Interleu-kin-18-induced human coronary artery smooth muscle cell migra-tion is dependent on NF-kappaB- and AP-1 -mediated matrix met-alloproteinase-9 expression and is inhibited by atorvastatin [ J ].J Biol Chem,2006,281(22) : 15099-15109.
  • 4礼希噥,刘闺男.非ST段抬高型心肌梗死患者GRACE危险积分与冠状动脉狭窄程度相关性分析[J] .中国循环杂志,2014,29(zl) :52-53.
  • 5Schmidt R,Btiltmann A,lingerer M,et al. Extracellular matrixmetalloproteinase inducer regulates matrix metalloproteinase activi-ty in cardiovascular cells : implications in acute myocardial infarc-tion [J]. Circulation, 2006,113(6) :834-841.
  • 6Holven KB, Halvorsen B, Bjerkeli V, et al. Impaired inhibitoryeffect of interleukin-10 on the balance between matrix metallopro-teinase-9 and its inhibitor in mononuclear cells from hyperhomo-cysteinemic subjects[ J]. Stroke, 2006,37(7) :1731-1736.
  • 7Mori M,Massaro A,Calderone V, et al. Discovery of a New Class ofPotent MMP Inhibitors by Structure-Based Optimization of the Aryl-sulfonamide Scaffold[J]. ACS Med Chem Lett, 2013,4(6) :565-569.
  • 8Guo C,Zhang S,Zhang J, et al. Correlation between the severityof coronary artery lesions and levels of estrogen, hs-CRP andMMP-9[J]. Exp Ther Med, 2014,7(5) :1177-1180.
  • 9Allal-Elasmi M, Zayani Y,Zidi W, et al. The measurement of cir-culating matrix metalloproteinase-8 and its tissue inhibitor andtheir association with inflammatory mediators in patients with acutecoronary syndrome[ J]. Clin Lab, 2014,60(6) :951-956.
  • 10吴焱贤.高同型半胱氨酸对HDL-C正常患者的冠脉病变和HDL功能的影响[D].南方医科大学2013

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部